Assessment of Cryptosporidium parvum infection in immunocompetent and immunocompromised mice and its role in triggering intestinal dysplasia.

Abstract

OBJECTIVES:

There is an association between chronic inflammation and cancer, including colon cancer. Cryptosporidium parvum is a protozoan parasite that infects the gastrointestinal epithelial cells causing several parasitological and pathological changes. It is incriminated in the development of colorectal cancer in immunosuppressed individuals. Cyclin D1 expression is essential for cell cycle progression and its overexpression has been reported in colorectal cancer. This work aimed to study the gastrointestinal changes, including parasitological and pathological changes, induced by C. parvum infection in both immunocompetent and in chemically immunosuppressed mice, together with immunohistochemical assessment of cyclin D1 expression in infected tissues. In addition, the effectiveness of nitazoxanide (NTZ) in the treatment of cryptosporidiosis was evaluated.

METHODS:

This study included six groups of mice: group I, infected; group II, infected and immunosuppressed; group III, infected and treated with NTZ; group IV, infected, immunosuppressed, and treated with NTZ; and groups V and VI representing non-infected controls. Mice were subjected to stool examination for oocyst counts and were later sacrificed for intestinal dissection and routine histopathological examination of pathological changes; the endogenous developmental stages of the parasite were counted and immunohistochemical staining was carried out for the determination of cyclin D1.

RESULTS:

Group II showed the highest numbers of oocysts shed and endogenous developmental stages compared to the other groups. Intestinal dysplastic changes were seen only in groups I and II, where these changes were in favor of group II compared to group I. High-grade dysplasia was seen in four out of 20 mice in group II and was significantly associated with the number of endogenous developmental stages of C. parvum. NTZ was effective in the treatment of Cryptosporidium infection, with a greater effect in group III than in group IV.

CONCLUSIONS:

C. parvum is one of the infectious agents that may induce intestinal dysplasia, including the high-grade category, which occurs particularly in the presence of immune suppression states and elevated endogenous parasite loads. Cyclin D1 is a good and useful marker for the detection of intestinal dysplasia. The effectiveness of NTZ is dependent on the immune status of the infected host.

• Authors: Asmaa Gaber Abdou, Nancy Mahmoud Harba, Amira Fathy Afifi, Nada Farag Elnaidany
• Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases (Int J Infect Dis) Vol. 17 Issue 8 Pg. e593-600 (Aug 2013) ISSN: 1878-3511 [Electronic] Canada
• PMID: 23291034 (Publication Type: Journal Article)
• Copyright: Copyright © 2012 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Chemical References

• Antiparasitic Agents
• Nitro Compounds
• Thiazoles
• Cyclin D1
• nitazoxanide

Topics

• Animals
• Antiparasitic Agents (administration & dosage, pharmacology)
• Cryptosporidiosis (drug therapy, immunology, parasitology, pathology)
• Cryptosporidium parvum (physiology)
• Cyclin D1 (metabolism)
• Disease Models, Animal
• Female
• Immunocompromised Host
• Intestinal Mucosa (metabolism, parasitology, pathology)
• Intestines (immunology, parasitology, pathology)
• Liver (parasitology, pathology)
• Mice
• Nitro Compounds
• Oocysts
• Thiazoles (administration & dosage, pharmacology)